Cargando…

A nomogram prediction model for lymph node metastasis in endometrial cancer patients

BACKGROUND: This study aimed to explore the risk factors for lymph node metastasis (LNM) in patients with endometrial cancer (EC) and develop a clinically useful nomogram based on clinicopathological parameters to predict it. METHODS: Clinical information of patients who underwent staging surgery fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhiling, Zhang, Shuo, Ma, Yifei, Li, Wenhui, Tian, Jiguang, Liu, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243766/
https://www.ncbi.nlm.nih.gov/pubmed/34187416
http://dx.doi.org/10.1186/s12885-021-08466-4
_version_ 1783715811825811456
author Wang, Zhiling
Zhang, Shuo
Ma, Yifei
Li, Wenhui
Tian, Jiguang
Liu, Ting
author_facet Wang, Zhiling
Zhang, Shuo
Ma, Yifei
Li, Wenhui
Tian, Jiguang
Liu, Ting
author_sort Wang, Zhiling
collection PubMed
description BACKGROUND: This study aimed to explore the risk factors for lymph node metastasis (LNM) in patients with endometrial cancer (EC) and develop a clinically useful nomogram based on clinicopathological parameters to predict it. METHODS: Clinical information of patients who underwent staging surgery for EC was abstracted from Qilu Hospital of Shandong University from January 1st, 2005 to June 31st, 2019. Parameters including patient-related, tumor-related, and preoperative hematologic examination-related were analyzed by univariate and multivariate logistic regression to determine the correlation with LNM. A nomogram based on the multivariate results was constructed and underwent internal and external validation to predict the probability of LNM. RESULTS: The overall data from the 1517 patients who met the inclusion criteria were analyzed. 105(6.29%) patients had LNM. According the univariate analysis and multivariate logistic regression analysis, LVSI is the most predictive factor for LNM, patients with positive LVSI had 13.156-fold increased risk for LNM (95%CI:6.834–25.324; P < 0.001). The nomogram was constructed and incorporated valuable parameters including histological type, histological grade, depth of myometrial invasion, LVSI, cervical involvement, parametrial involvement, and HGB levels from training set. The nomogram was cross-validated internally by the 1000 bootstrap sample and showed good discrimination accuracy. The c-index for internal and external validation of the nomogram are 0.916(95%CI:0.849–0.982) and 0.873(95%CI:0.776–0.970), respectively. CONCLUSIONS: We developed and validated a 7-variable nomogram with a high concordance probability to predict the risk of LNM in patients with EC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08466-4.
format Online
Article
Text
id pubmed-8243766
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82437662021-06-30 A nomogram prediction model for lymph node metastasis in endometrial cancer patients Wang, Zhiling Zhang, Shuo Ma, Yifei Li, Wenhui Tian, Jiguang Liu, Ting BMC Cancer Research Article BACKGROUND: This study aimed to explore the risk factors for lymph node metastasis (LNM) in patients with endometrial cancer (EC) and develop a clinically useful nomogram based on clinicopathological parameters to predict it. METHODS: Clinical information of patients who underwent staging surgery for EC was abstracted from Qilu Hospital of Shandong University from January 1st, 2005 to June 31st, 2019. Parameters including patient-related, tumor-related, and preoperative hematologic examination-related were analyzed by univariate and multivariate logistic regression to determine the correlation with LNM. A nomogram based on the multivariate results was constructed and underwent internal and external validation to predict the probability of LNM. RESULTS: The overall data from the 1517 patients who met the inclusion criteria were analyzed. 105(6.29%) patients had LNM. According the univariate analysis and multivariate logistic regression analysis, LVSI is the most predictive factor for LNM, patients with positive LVSI had 13.156-fold increased risk for LNM (95%CI:6.834–25.324; P < 0.001). The nomogram was constructed and incorporated valuable parameters including histological type, histological grade, depth of myometrial invasion, LVSI, cervical involvement, parametrial involvement, and HGB levels from training set. The nomogram was cross-validated internally by the 1000 bootstrap sample and showed good discrimination accuracy. The c-index for internal and external validation of the nomogram are 0.916(95%CI:0.849–0.982) and 0.873(95%CI:0.776–0.970), respectively. CONCLUSIONS: We developed and validated a 7-variable nomogram with a high concordance probability to predict the risk of LNM in patients with EC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-021-08466-4. BioMed Central 2021-06-29 /pmc/articles/PMC8243766/ /pubmed/34187416 http://dx.doi.org/10.1186/s12885-021-08466-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Wang, Zhiling
Zhang, Shuo
Ma, Yifei
Li, Wenhui
Tian, Jiguang
Liu, Ting
A nomogram prediction model for lymph node metastasis in endometrial cancer patients
title A nomogram prediction model for lymph node metastasis in endometrial cancer patients
title_full A nomogram prediction model for lymph node metastasis in endometrial cancer patients
title_fullStr A nomogram prediction model for lymph node metastasis in endometrial cancer patients
title_full_unstemmed A nomogram prediction model for lymph node metastasis in endometrial cancer patients
title_short A nomogram prediction model for lymph node metastasis in endometrial cancer patients
title_sort nomogram prediction model for lymph node metastasis in endometrial cancer patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243766/
https://www.ncbi.nlm.nih.gov/pubmed/34187416
http://dx.doi.org/10.1186/s12885-021-08466-4
work_keys_str_mv AT wangzhiling anomogrampredictionmodelforlymphnodemetastasisinendometrialcancerpatients
AT zhangshuo anomogrampredictionmodelforlymphnodemetastasisinendometrialcancerpatients
AT mayifei anomogrampredictionmodelforlymphnodemetastasisinendometrialcancerpatients
AT liwenhui anomogrampredictionmodelforlymphnodemetastasisinendometrialcancerpatients
AT tianjiguang anomogrampredictionmodelforlymphnodemetastasisinendometrialcancerpatients
AT liuting anomogrampredictionmodelforlymphnodemetastasisinendometrialcancerpatients
AT wangzhiling nomogrampredictionmodelforlymphnodemetastasisinendometrialcancerpatients
AT zhangshuo nomogrampredictionmodelforlymphnodemetastasisinendometrialcancerpatients
AT mayifei nomogrampredictionmodelforlymphnodemetastasisinendometrialcancerpatients
AT liwenhui nomogrampredictionmodelforlymphnodemetastasisinendometrialcancerpatients
AT tianjiguang nomogrampredictionmodelforlymphnodemetastasisinendometrialcancerpatients
AT liuting nomogrampredictionmodelforlymphnodemetastasisinendometrialcancerpatients